OraSure Technologies | OSUR - 贸易债权人



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 288.2M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


贸易债权人 更改 日
Agilent USD 608M 7M 2026-06
AngioDynamics USD 35.39M 3.51M 2025-09
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Bio Techne USD 26.7M 68.9M 2026-06
Bio-Rad Laboratories USD 143.5M 10.4M 2026-06
Bruker USD 200.2M 68.9M 2026-06
Cerus USD 28.01M 2.54M 2025-12
Charles River Laboratories USD 140.98M 7.03M 2026-06
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 260M 1000K 2026-06
Dexcom USD 2.08B 134.8M 2026-06
Illumina USD 230M 12M 2026-06
Integra LifeSciences USD 82.64M 5.31M 2026-06
Intuitive Surgical USD 1.92B 66.6M 2026-06
IQVIA Holdings USD 3.61B 31M 2026-06
Mesa Laboratories USD 5.25M 163K 2025-12
Mettler Toledo International USD 229.8M 1.08M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
OraSure Technologies USD 8.4M 2.23M 2026-06
Quidel USD 236.5M 7M 2026-06
Repligen USD 33.23M 1.42M 2026-06
Revvity USD 165.74M 3.94M 2026-06
STAAR Surgical USD 13.48M 4.78M 2026-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Trinity Biotech USD 11.48M 18.88M 2025-12
Waters USD 602M 498.22M 2026-03